{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:47:33Z","timestamp":1773409653080,"version":"3.50.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Pressure"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1080\/08037050510008959","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T14:43:58Z","timestamp":1126017838000},"page":"170-176","source":"Crossref","is-referenced-by-count":10,"title":["Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate\u2010to\u2010severe reductions in renal function"],"prefix":"10.1080","volume":"14","author":[{"given":"Marie","family":"Gr\u00f8n s\u00e6len","sequence":"first","affiliation":[{"name":"Department of Pharmacotherapeutics, University of Oslo, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Katrine pr\u00f8sch","sequence":"additional","affiliation":[{"name":"Ullev\u00e5l University Hospital, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Gudmundsdottir","sequence":"additional","affiliation":[{"name":"Vestfold HF, T\u00f8nsberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagfinn","family":"Dyrbekk","sequence":"additional","affiliation":[{"name":"\u00d8stfold HF, Fredrikstad"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odd","family":"Helge Hunderi","sequence":"additional","affiliation":[{"name":"Innlandet HF\u2010Elverum, Elverum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Arnesen","sequence":"additional","affiliation":[{"name":"Innlandet HF\u2010Lillehammer, Lillehammer"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dag","family":"Paulsen","sequence":"additional","affiliation":[{"name":"Akershus University Hospital, Nordbyhagen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helge","family":"Skj\u00f8nsberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapeutics, University of Oslo, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Os","sequence":"additional","affiliation":[{"name":"Ullev\u00e5l University Hospital, Oslo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-7-200304010-00010"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-2-200107170-00007"},{"key":"e_1_2_1_7_1","first-page":"939","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency","volume":"334","author":"Maschio G","year":"1996","unstructured":"Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med. 1996;334:939\u2013945.","journal-title":"The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med"},{"issue":"1","key":"e_1_2_1_8_1","first-page":"S16","article-title":"Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial","volume":"33","author":"Maschio G","year":"1999","unstructured":"Maschio G, Alberti D, Locatelli F, Mann JF, Motolese M, Ponticelli C, et al. Angiotensin-converting enzyme inhibitors and kidney protection: The AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group. J Cardiovasc Pharmacol. 1999;33 Suppl 1:S16\u201320.","journal-title":"The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group. J Cardiovasc Pharmacol"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12229-5"},{"key":"e_1_2_1_10_1","first-page":"1440","volume":"321","author":"Mogensen CE","year":"2000","unstructured":"Mogensen CE, Neldam S, Tikkannen I, Oren S, Viskoper R, Watts RW, Cooper ME. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study. BMJ. 2000;321:1440\u20131444.","journal-title":"Cooper ME. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study. BMJ"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.9.1025"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","unstructured":"Kuriyama S Tomonari H Abe A Imasawa T Hosoya T. Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy. Nephron. 2000;86: 529\u2013530.","DOI":"10.1159\/000045855"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.suppl_1.67"},{"key":"e_1_2_1_14_1","first-page":"2157","article-title":"Ball A, Stehman-Breen C","volume":"61","author":"Kestenbaum B","year":"2002","unstructured":"Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C. Calcium channel blocker use and mortal-ity among patients with end-stage renal disease. Kidney Int. 2002;61:2157\u20132164.","journal-title":"Calcium channel blocker use and mortal-ity among patients with end-stage renal disease. Kidney Int"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1042\/cs1030511"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2719"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.028"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.93"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","unstructured":"Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr et al. The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure: The JNC 7 report. JAN1A. 2003;289: 2560\u20132572.","DOI":"10.1001\/jama.289.19.2560"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hyper-tension. J Hypertens. 2003;21: 1011\u20131053.","DOI":"10.1097\/00004872-200306000-00001"},{"issue":"21","key":"e_1_2_1_21_1","first-page":"1983","article-title":"World Health Organization (WHO)\/ International Society of Hypertension (ISH) statement on management of hypertension","volume":"2003","author":"Whitworth JA","year":"2003","unstructured":"Whitworth JA. 2003 World Health Organization (WHO)\/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21:1983\u20131992.","journal-title":"J Hypertens"},{"key":"e_1_2_1_22_1","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation classification and stratification. Am J Kidney Dis. 2002;39:S1\u2013266."},{"key":"e_1_2_1_23_1","first-page":"641","article-title":"Achievement and safety of a low blood pressure goal in chronic renal disease","volume":"29","author":"Lazarus JM","year":"1997","unstructured":"Lazarus JM, Bourgoignie JJ, Buckalew VM, Greene T, Levey AS, Milas NC, et al. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group. Hypertension. 1997;29:641\u2013650.","journal-title":"The Modification of Diet in Renal Disease Study Group. Hypertension"},{"key":"e_1_2_1_24_1","first-page":"1802","article-title":"Close CF","volume":"26","author":"Tomlinson JW","year":"2003","unstructured":"Tomlinson JW, Owen KR, Close CF. Treating hypertension in diabetic nephropathy. Diabetes Care. 2003;26:1802\u20131805.","journal-title":"Treating hypertension in diabetic nephropathy. Diabetes Care"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.3.803"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","unstructured":"Prosch LK Sxlen MG Gudmundsdottir H Dyrbekk D Hunderi OH Arnesen E et al. Blood pressure control is hard to obtain in patients with chronic renal failure. Results from a survey in renal units in Norway. Scand J Urol Nephrol. 2005; in press.","DOI":"10.1080\/00365590510007810-1"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_2_1_28_1","first-page":"1207","article-title":"Klag MJ","volume":"161","author":"Coresh J","year":"2001","unstructured":"Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ. Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001; 161:1207\u20131216.","journal-title":"Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00213.x"},{"key":"e_1_2_1_30_1","first-page":"37","article-title":"Olsen H","volume":"10","author":"Westheim A","year":"2001","unstructured":"Westheim A, Klemetsrud T, Tretli S, Stokke HP, Olsen H. Blood pressure levels in treated hypertensive patients in general practice in Norway. Blood Press. 2001;10:37\u201342.","journal-title":"Blood pressure levels in treated hypertensive patients in general practice in Norway. Blood Press"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00273.x"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","unstructured":"Weir MR. Are drugs that block the renin-angiotensin system effective and safe in patients with renal insufficiency? Am J Hypertens. 1999;12:1955\u20132035.","DOI":"10.1016\/S0895-7061(99)00104-1"},{"key":"e_1_2_1_33_1","first-page":"428","article-title":"Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency","volume":"15","author":"Pisoni R","year":"2002","unstructured":"Pisoni R, Faraone R, Ruggenent P, Remuzzi G. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency. J Nephrol. 2002;15:428\u2013430.","journal-title":"J Nephrol"},{"key":"e_1_2_1_34_1","first-page":"2832","volume":"12","author":"Ruggenenti P","year":"2001","unstructured":"Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop. A post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol. 2001;12:2832\u20132837.","journal-title":"Remuzzi G. ACE inhibitors to prevent end-stage renal disease: When to start and why possibly never to stop. A post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol"}],"container-title":["Blood Pressure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08037050510008959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:20:46Z","timestamp":1770891646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/08037050510008959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1080\/08037050510008959"],"URL":"https:\/\/doi.org\/10.1080\/08037050510008959","relation":{},"ISSN":["0803-7051","1651-1999"],"issn-type":[{"value":"0803-7051","type":"print"},{"value":"1651-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}